50¶È»Ò

The master's programme in Molecular Biotechnology and Bioinformatics trains students to analyse complex biological data from genomics, proteomics, and imaging, tackling global challenges in medicine, food production, and sustainability.

Combining biotechnology and bioinformatics, graduates are equipped to lead the fast-evolving data-driven life science sector. This is a new programme opening for application in October 2025.

Application deadlines for studies starting August 2026

• 16 October (2025): Application opens
• 15 January: Last day to apply
• 2 February: Submit documents and, if required, pay application fee
• 26 March: Admission results announced

Molecular Biotechnology and Bioinformatics at KTH:

The master's programme in Molecular Biotechnology and Bioinformatics prepares students to address the growing need for experts to manage, analyse, and interpret the vast amounts of biological data generated by modern experimental technologies.

It provides a unique combination of knowledge in molecular life sciences, biotechnology, and computational data analysis, skills that are increasingly critical in research, healthcare, environmental science, and industrial biotechnology.

You will explore a broad range of topics at the intersection of biology, computer science and engineering. The programme covers areas such as:

• Omics technologies, including genomics, transcriptomics, proteomics, metabolomics and epigenomics
• Subcellular and structural imaging, including cryo-electron microscopy and tomography
• Data analysis, statistics, probability, dimensionality reduction and machine learning
• Systems biology and modelling of metabolic and regulatory networks
• Integration of large-scale, multimodal datasets from public and private databases

Programme Overview:

While the programme does not have formal tracks, students can tailor their education through elective courses in advanced data analysis, machine learning, and visualisation, provided in collaboration with KTH's School of Electrical Engineering and Computer Science.

Project-based learning is integrated throughout the curriculum, including real-world case studies derived from ongoing research. Students work with large biological datasets and may participate in research environments affiliated with initiatives such as the SciLifeLab, Human Protein Atlas and Alpha Cell.

The programme is tightly connected to cutting-edge research at KTH, especially within the Departments of Gene Technology and Protein Science. Teaching is delivered by faculty who are pioneers in areas such as spatial transcriptomics and proteomics, technologies recognised by Nature as Methods of the Year in 2021 and 2024.

Future and career:

The master's programme in Molecular Biotechnology and Bioinformatics prepares you for a growing number of roles at the intersection of biotechnology, data science, and life science innovation. As molecular biology becomes increasingly data-driven, there is a strong demand for professionals who can bridge experimental biology with computational analysis. By combining deep domain knowledge with strong computational skills, we prepare graduates to drive innovation across research, industry, and healthcare.

Graduates of the programme will be well-equipped to work in:

• The pharmaceutical and biotechnology industries
• Startups and established companies within diagnostics, therapeutics and bioinformatics
• Public agencies and research institutes focused on healthcare, environment, and agriculture
• Emerging fields such as precision fermentation, synthetic biology, and sustainable bioproduction

Typical job roles include data analyst, research scientist, bioinformatics specialist, systems biologist, and R&D engineer. Graduates can also work in interdisciplinary teams focused on innovation in life science tools, AI applications in biology, or omics-based diagnostics.

The programme benefits from close ties to Sweden's dynamic life science sector. Previous graduates from related KTH programmes have found employment at companies such as AstraZeneca, Sobi, 10X Genomics, Pelago Bioscience, Atlas Antibodies, Xbrane Biopharma, Pixelgen, Navinci Diagnostics, public agencies such as the Swedish Tax Agency and innovation-driven tech companies.

The programme also provides a strong foundation for doctoral studies in biotechnology, computational biology, or systems medicine. Students may continue to PhD programmes at KTH, Karolinska Institutet, Uppsala University, or other leading universities in Sweden and internationally.